No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: During the three and nine months ended February 29, 2012, TPL entered into licen

<During the three and nine months ended February 28, 2013, PDS recognized revenues of $1,500,000 for license agreements previously entered into by TPL.>

Must have been one of those contingent licenses. Are there any more out there?

Opty


Share
New Message
Please login to post a reply